Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Original Biomedicals CoROCO:6483 -0.81%33 PS Ratio is 2,041.67 as of Jul. 26, 2026, which is 6701% above its 10-year median of 30.02. GuruFocus rates ROCO:6483 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 954 Drug Manufacturers companies, Original Biomedicals Co ranks worse than 99.69% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Original Biomedicals Co's share price is NT$12.25.
Original Biomedicals Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.01. Hence, Original Biomedicals Co's PS Ratio for today is 2,041.67.
Good Sign:
Original Biomedicals Co Ltd stock PS Ratio (=2041.67) is close to 3-year low of 1991.67.
The historical rank and industry rank for Original Biomedicals Co's PS Ratio or its related term are showing as below:
ROCO:6483'
s PS Ratio Range Over the Past 10 Years
Min: 30.02 Med: 30.02 Max: 20050
Current: 2041.67
During the past 9 years, Original Biomedicals Co's highest PS Ratio was 20050.00. The lowest was 30.02. And the median was 30.02.
ROCO:6483's PS Ratio is ranked worse than 99.69% of 954
companies
in the Drug Manufacturers industry
Industry Median: 2.245
vs ROCO:6483: 2041.67
During the past 3 years, the average Revenue per Share Growth Rate was 44.20% per year.
During the past 9 years, Original Biomedicals Co's highest 3-Year average Revenue per Share Growth Rate was 44.20% per year. The lowest was -88.00% per year. And the median was -21.90% per year.
Back to Basics: PS Ratio
Original Biomedicals Co (ROCO:6483) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Original Biomedicals Co PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Original Biomedicals Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Original Biomedicals Co's Share Price of today is NT$12.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Original Biomedicals Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Original Biomedicals Co (ROCO:6483) has a PS Ratio of 2,041.67 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Original Biomedicals Co and its competitors. This is 6701% above median its historical median of 30.02. Over the past decade, Original Biomedicals Co's PS Ratio has ranged from 30.02 to 20,050.00. According to the industry distribution chart, Original Biomedicals Co ranks #951 out of 954 companies in the Drug Manufacturers industry, placing it in the top 99.7%.
Is Original Biomedicals Co's PS Ratio too high?
Original Biomedicals Co's current PS Ratio of 2,041.67 is 6701% above median its 10-year median of 30.02. Over the past 10 years, this metric has ranged from a low of 30.02 to a high of 20,050.00. The Drug Manufacturers industry median PS Ratio is 2.25. Original Biomedicals Co's value of 2,041.67 is 90843% above this industry median. Based on the distribution chart, Original Biomedicals Co ranks #951 out of 954 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Original Biomedicals Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Original Biomedicals Co ranks #951 out of 954 companies for PS Ratio. This places Original Biomedicals Co in the lower half of its industry. The industry median PS Ratio is 2.25. Original Biomedicals Co's value of 2,041.67 is 90843% above this benchmark. Historically, Original Biomedicals Co's own PS Ratio has ranged from 30.02 to 20,050.00 over the past decade. While the company's 10-year median is 30.02 vs. the industry median of 2.25, Original Biomedicals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.25, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Original Biomedicals Co's current PS Ratio of 2,041.67 is 90843% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Original Biomedicals Co and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Original Biomedicals Co's current PS Ratio is 2,041.67, which is 6701% above median its own 10-year median of 30.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current PS Ratio of 2,041.67. The current PS Ratio is 2,041.67, which is 6701% above median its 10-year median of 30.02 and 90843% above the Drug Manufacturers industry median of 2.25. Original Biomedicals Co's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current PS Ratio is 2,041.67 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
33GF Score
Get the complete analysis for ROCO:6483
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6483 has been successfully added to your 
